Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    November 2018
  1. HUANG TL, Chen TY, Tsang LC, Ou HY, et al
    Acoustic Radiation Force Impulse Elastography in Post-transplant Recurrent Hepatitis C in Living Donor Liver Transplantation.
    Transplant Proc. 2018;50:2695-2698.
    PubMed     Text format     Abstract available


  2. JUNG BH, Park JI, Lee SG
    Successful Treatment of Fibrosing Cholestatic Hepatitis With Daclatasvir and Asunaprevir After Liver Transplantation: A Case Report.
    Transplant Proc. 2018;50:2877-2881.
    PubMed     Text format     Abstract available


    September 2018
  3. WOJTOWICZ M, Wilkowski P, Hryniewiecka E, Cieciura T, et al
    Effect of Successful Treatment of Hepatitis C Virus Infection Recurrence With Direct-Acting Antiviral Agents on Physical Performance in Liver Transplant Recipients.
    Transplant Proc. 2018;50:2027-2030.
    PubMed     Text format     Abstract available


    July 2018
  4. PLISZCZYNSKI J, Jasztal K, Jozwik A, Kosieradzki M, et al
    Results of Renal Transplant From Deceased Anti-hepatitis C Virus Donors, Poland 1998-2012.
    Transplant Proc. 2018;50:1691-1696.
    PubMed     Text format     Abstract available


  5. WAZNA E, Pazik J, Perkowska-Ptasinska A, Durlik M, et al
    Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome?
    Transplant Proc. 2018;50:1765-1768.
    PubMed     Text format     Abstract available


    June 2018
  6. GARCIA-PAJARES F, Tejedor-Tejada J, Torres-Yuste R, Almohalla-Alvarez C, et al
    Efficacy of Direct-acting Antivirals to Improve Clinical Condition, Fibrosis, and Liver Function in Liver Transplant Recipients Infected by Hepatitis C.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30877.
    PubMed     Text format     Abstract available


  7. RAYA AM
    Influence of Donor Obesity on Long-Term Liver Transplantation Outcomes.
    Transplant Proc. 2018 Jun 30. pii: S0041-1345(18)30837.
    PubMed     Text format     Abstract available


  8. PESCHEL G, Moleda L, Baier L, Selgrad M, et al
    Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study.
    Transplant Proc. 2018;50:1444-1450.
    PubMed     Text format     Abstract available


  9. BODRO M, Sanclemente G, Crespo G, Linares L, et al
    Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.
    Transplant Proc. 2018;50:1437-1443.
    PubMed     Text format     Abstract available


  10. WAHAB MA, Shehta A, Elshoubary M, Yassen AM, et al
    Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
    Transplant Proc. 2018;50:1396-1406.
    PubMed     Text format     Abstract available


    April 2018
  11. IMAI H, Kamei H, Onishi Y, Ishizu Y, et al
    Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus.
    Transplant Proc. 2018 Apr 25. pii: S0041-1345(18)30211.
    PubMed     Text format     Abstract available


  12. ORUC A, Ersoy A
    Transplantation Opportunities of Hepatitis C Virus-Seropositive Patients on the Kidney Waiting List.
    Transplant Proc. 2018 Apr 18. pii: S0041-1345(18)30614.
    PubMed     Text format     Abstract available


  13. TAKEUCHI S, Takamura M, Yoshida T, Takahashi K, et al
    Ombitasvir-Paritaprevir-Ritonavir Therapy in a Kidney Transplant Recipient With Chronic Hepatitis C Virus Genotype 1 Infection: A Case Report on the Importance of Considering Drug-Drug Interactions and Monitoring Cyclosporine Levels.
    Transplant Proc. 2018;50:884-886.
    PubMed     Text format     Abstract available


  14. WEIGERT A, Querido S, Carvalho L, Lebre L, et al
    Hepatitis C Virus Eradication in Kidney Transplant Recipients: A Single-Center Experience in Portugal.
    Transplant Proc. 2018;50:743-745.
    PubMed     Text format     Abstract available


  15. MUCENIC M, Bandeira de Mello Brandao A, Marroni CA, Medeiros Fleck A Jr., et al
    Daclatasvir and Sofosbuvir With or Without Ribavirin in Liver Transplant Recipients: A Single-Center Real-World Study.
    Transplant Proc. 2018;50:769-771.
    PubMed     Text format     Abstract available


  16. MARTINO RB, Waisberg DR, Dias APM, Inoue VBS, et al
    Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study.
    Transplant Proc. 2018;50:758-761.
    PubMed     Text format     Abstract available


    March 2018
  17. NOGUERAS LOPEZ F, Lopez Garrido A, Ortega Suazo EJ, Vadillo Calles F, et al
    Therapy With Direct-Acting Antiviral Agents for Hepatitis C in Liver Transplant Recipients.
    Transplant Proc. 2018;50:631-633.
    PubMed     Text format     Abstract available


  18. CAICEDO LA, Delgado A, Garcia VH, Aristizabal AM, et al
    Liver Transplantation in Hepatitis C-Infected Patients: Experience From a South American Transplant Center.
    Transplant Proc. 2018;50:493-498.
    PubMed     Text format     Abstract available


    January 2018
  19. MIUMA S, Miyaaki H, Miyazoe Y, Suehiro T, et al
    Development of Duodenal Ulcers due to the Discontinuation of Proton Pump Inhibitors After the Induction of Sofosbuvir Plus Ledipasvir Therapy: A Report of Two Cases.
    Transplant Proc. 2018;50:222-225.
    PubMed     Text format     Abstract available


    December 2017
  20. MOTOMURA T, Yoshizumi T, Ohira M, Mano Y, et al
    Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:2409-2410.
    PubMed     Text format     Abstract available


    November 2017
  21. TOWNSEND SA, Monga MA, Nightingale P, Mutimer D, et al
    Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
    Transplant Proc. 2017;49:2129-2134.
    PubMed     Text format     Abstract available


  22. ROULLET S, Defaye M, Quinart A, Adam JP, et al
    Liver Transplantation With Old Grafts: A Ten-Year Experience.
    Transplant Proc. 2017;49:2135-2143.
    PubMed     Text format     Abstract available


    October 2017
  23. FREY A, Ecker EM, Piras-Straub K, Walker A, et al
    Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
    Transplant Proc. 2017;49:1947-1955.
    PubMed     Text format     Abstract available


  24. LIAO HT, Tan P, Huang JW, Yuan KF, et al
    Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis.
    Transplant Proc. 2017;49:1855-1863.
    PubMed     Text format     Abstract available


    September 2017
  25. SHAFII AE, Harris DD 2nd, Baz M
    Clearance of Hepatitis C Virus Prior to Lung Transplantation: A Case Report.
    Transplant Proc. 2017;49:1682-1684.
    PubMed     Text format     Abstract available


  26. NAKANO R, Ohira M, Ishiyama K, Ide K, et al
    Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report.
    Transplant Proc. 2017;49:1634-1638.
    PubMed     Text format     Abstract available


    July 2017
  27. TRONINA O, Slubowska K, Mikolajczyk-Korniak N, Komuda-Leszek E, et al
    Fibrosing Cholestatic Hepatitis C After Liver Transplantation: Therapeutic Options Before and After Introduction of Direct-Acting Antivirals: Our Experience and Literature Review.
    Transplant Proc. 2017;49:1409-1418.
    PubMed     Text format     Abstract available


    June 2017
  28. OHIRA M, Nishida S, Tryphonopoulos P, Ruiz P, et al
    Impact of Steroids on Natural Killer Cells Against Cytotoxicity and Hepatitis C Virus Replication.
    Transplant Proc. 2017;49:1160-1164.
    PubMed     Text format     Abstract available


  29. KOSHINO K, Ushigome H, Masuda K, Matsuyama T, et al
    Effective Treatment With Daclatasvir and Asunaprevir in Kidney Transplant Patients Infected With Hepatitis C Virus: A Report of Two Cases.
    Transplant Proc. 2017;49:1053-1055.
    PubMed     Text format     Abstract available


    May 2017
  30. PIAI G, Miglioresi L, Valente G
    Eradication of Hepatitis C After Liver Transplantion: Consequences for the Organization of the Transplant Patient's Follow-up.
    Transplant Proc. 2017;49:671-673.
    PubMed     Text format     Abstract available


  31. TRAPANI S, Rizzato L, Masiero L, Ricci A, et al
    Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
    Transplant Proc. 2017;49:658-666.
    PubMed     Text format     Abstract available


    January 2017
  32. MELLO F, Girao C, Castro CC, Fiuza S, et al
    De Mello's Single Incision for Combined Liver-kidney Transplantation, Keeping the Kidney Retroperitoneal: A Case Report.
    Transplant Proc. 2017;49:169-171.
    PubMed     Text format     Abstract available


    November 2016
  33. DENG G, Ma J, Shen S, Li Q, et al
    Sofosbuvir Monotherapy for Asymptomatic and Noncirrhotic Hepatitis C Infection in a Renal Retransplantation Recipient: A Case Report.
    Transplant Proc. 2016;48:3120-3122.
    PubMed     Text format     Abstract available


  34. SANCHEZ ANTOLIN G, Testillano M, Pascasio JM, Narvaez Rodriguez I, et al
    Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort.
    Transplant Proc. 2016;48:3013-3016.
    PubMed     Text format     Abstract available


  35. BERGE E, Oton E, Reina Z, Diaz L, et al
    Predictors of Poor Prognosis in Recurrent Hepatitis C After Liver Transplantation.
    Transplant Proc. 2016;48:2997-2999.
    PubMed     Text format     Abstract available


  36. GENTIL MA, Gonzalez-Corvillo C, Perello M, Zarraga S, et al
    Hepatitis C Treatment With Direct-Acting Antivirals in Kidney Transplant: Preliminary Results From a Multicenter Study.
    Transplant Proc. 2016;48:2944-2946.
    PubMed     Text format     Abstract available


  37. SUAREZ BENJUMEA A, Gonzalez-Corvillo C, Sousa JM, Bernal Blanco G, et al
    Hepatitis C Virus in Kidney Transplant Recipients: A Problem on the Path to Eradication.
    Transplant Proc. 2016;48:2938-2940.
    PubMed     Text format     Abstract available


  38. GARCIA BERNARDO CM, Arguelles Garcia B, Redondo Buil P, Miyar de Leon A, et al
    Collateral Development in Thrombosis of the Hepatic Artery After Transplantation.
    Transplant Proc. 2016;48:3006-3009.
    PubMed     Text format     Abstract available


  39. SAFWAN M, Nagai S, Abouljoud MS
    Portal Vein Inflow From Enlarged Coronary Vein in Liver Transplantation: Surgical Approach and Technical Tips: A Case Report.
    Transplant Proc. 2016;48:3070-3072.
    PubMed     Text format     Abstract available


  40. CEPEDA-FRANCO C, Bernal-Bellido C, Barrera-Pulido L, Alamo-Martinez JM, et al
    Survival Outcomes in Liver Transplantation With Elderly Donors: Analysis of Andalusian Transplant Register.
    Transplant Proc. 2016;48:2983-2986.
    PubMed     Text format     Abstract available


    October 2016
  41. ALDEMIR E, Coskunol H, Kilic M, Sert I, et al
    Treatment of Opioid Dependence With Buprenorphine/Naloxone After Liver Transplantation: Report of Two Cases.
    Transplant Proc. 2016;48:2769-2772.
    PubMed     Text format     Abstract available


    September 2016
  42. BENITEZ-GUTIERREZ L, de Mendoza C, Banos I, Duca A, et al
    Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.
    Transplant Proc. 2016;48:2515-2518.
    PubMed     Text format     Abstract available


    June 2016
  43. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Transplant Registry in Poland: Web-Netted Quality Tool in Liver Transplantation From Deceased and Living Donors.
    Transplant Proc. 2016;48:1347-9.
    PubMed     Text format     Abstract available


  44. CZERWINSKI J, Lewandowska D, Malkowski P, Danielewicz R, et al
    Liver Donation and Transplantation in Poland: Numbers, Indicators, and Trends.
    Transplant Proc. 2016;48:1341-6.
    PubMed     Text format     Abstract available


    May 2016
  45. ASAVAKARN S, Sirivatanauksorn Y, Promraj R, Ruenrom A, et al
    Systematic Pharmaceutical Educational Approach to Enhance Drug Adherence in Liver Transplant Recipients.
    Transplant Proc. 2016;48:1202-7.
    PubMed     Text format     Abstract available


  46. KANG GW, Lee IH, Ahn KS, Kim JD, et al
    One-Year Follow-up of the Changes in Renal Function After Liver Transplantation in Patients Without Chronic Kidney Disease.
    Transplant Proc. 2016;48:1190-3.
    PubMed     Text format     Abstract available


    March 2016
  47. MORABITO V, Grossi P, Lombardini L, Ricci A, et al
    Solid Organ Transplantation in HIV+ Recipients: Italian Experience.
    Transplant Proc. 2016;48:424-30.
    PubMed     Text format     Abstract available


  48. FERLA F, Mariani A, di Sandro S, Buscemi V, et al
    Do Older Liver Grafts Have Worse Survival? The Niguarda Experience.
    Transplant Proc. 2016;48:362-5.
    PubMed     Text format     Abstract available


    January 2016
  49. LAM PH, Obirieze AC, Ortega G, Nwokeabia I, et al
    Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
    Transplant Proc. 2016;48:123-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: